Management of Spondylosis

Initial Treatment Approach

The American College of Rheumatology recommends starting NSAIDs at the lowest effective dose initially, then titrating to maximum tolerated doses, while weighing cardiovascular, gastrointestinal, and renal risks against benefits 3, 1, 2
Continuous NSAID use is preferred over on-demand dosing for patients who respond well and remain symptomatic 3, 1, 2
If the first NSAID is ineffective after 2-4 weeks, trial a different NSAID before escalating therapy 1, 2
For patients with gastrointestinal risk factors, consider COX-2 selective NSAIDs or add gastroprotective agents 2
Approximately 75% of patients with axial spondyloarthritis show good or very good response within 48 hours of full-dose NSAID therapy 1, 2

All patients must be referred to a specialist for structured exercise programs, as these are more beneficial than home exercises alone 1, 2
Physical therapy should be considered for all patients with spondylosis 1, 2
Hydrotherapy can be considered for pain management 1
Smoking cessation is essential, as smoking worsens disease progression 2

Refer to a rheumatologist when patients have chronic low back pain (>3 months) starting before age 45 PLUS at least 4 of the following: back pain occurring before age 35, waking at night due to back pain symptoms, buttock pain, improvement in pain with movement or within 2 days of taking an NSAID, first-degree relative with spondyloarthritis, or current or previous arthritis, enthesitis, or psoriasis 1, 2
Persistently high disease activity despite 2-4 weeks of optimal NSAID therapy is a trigger for referral to rheumatology 1, 2
Difficulties performing activities of daily living despite NSAID treatment is a trigger for referral to rheumatology 1, 2
Presence of inflammatory back pain characterized by morning stiffness >30 minutes, pain at night/early morning, and improvement with exercise is a trigger for referral to rheumatology 4, 5
HLA-B27 positivity in a patient with chronic back pain (post-test probability of 32% for axial SpA) is a trigger for referral to rheumatology 4, 5, 6
Evidence of sacroiliitis on x-ray or MRI imaging is a trigger for referral to rheumatology 4, 5

Before referring to rheumatology, obtain ESR and CRP 2
Before referring to rheumatology, obtain HLA-B27 testing 2
Before referring to rheumatology, obtain complete blood count 2
Consider plain radiographs of sacroiliac joints (though MRI is more sensitive for detecting early sacroiliitis) before referring to rheumatology 2

Do not rule out axial spondyloarthritis based solely on negative HLA-B27 or normal inflammatory markers (ESR/CRP), as 10% of patients are HLA-B27 negative and 50% have normal inflammatory markers 1, 2
The typical delay between symptom onset and diagnosis is 5-7 years—maintain high clinical suspicion for inflammatory back pain patterns 1, 2
Plain radiographs may be normal early in disease; MRI is more sensitive for detecting sacroiliitis 2
Do not use conventional DMARDs (methotrexate, sulfasalazine, leflunomide) for purely axial disease—they are ineffective 3, 2
Sulfasalazine may only be considered if peripheral arthritis is present 3, 2
Systemic glucocorticoids for axial disease are not supported by evidence 3

For patients referred to rheumatology with persistently high disease activity despite NSAIDs and physical therapy, biologic DMARDs (TNF inhibitors or IL-17 inhibitors) become the next treatment step 3, 2
Anti-TNF therapy should be given to patients with persistently high disease activity despite conventional treatments 3
Switching to a second TNF blocker might be beneficial, especially in patients with loss of response 3